IDB-001
IDB-001 is an inhibitor of ribosome PTC that inhibits protein synthesis in a sequence-selective manner. IDB-001 inhibits HCC-1143 with a EC50 value of 0.84 μM. IDB-001 inhibits MYC-dependent cancer cell viability[1].
Product Specifications
CAS Number
3079913-81-5
UNSPSC
12352211
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Concentration
10mM
Purity
99.48
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NCC[C@@H]1CCCN1)O[C@H]([C@H](CN2)O)[C@H]2CC3=CC=C(C=C3)OC
Molecular Formula
C19H29N3O4
Molecular Weight
363.45
References & Citations
[1]Paige D. Diamond, et al. Context-dependent translation inhibition as a novel oncology therapeutic modality. bioRxiv. January 09, 2025.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742479-500 1x 500 µL
CD3e (T-Cell Marker) (C3e/2479), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 